Progranulin in neurodegenerative diseases
Neurodegenerative diseases as a group of congenital or acquired diseases of the nervous system are currently more common in the aging societies, being one of the most severe diseases faced the healthcare services. Many scientific teams are searching for a better understanding of the mechanisms of these diseases, i.e.
Barbara Harmata +3 more
openaire +1 more source
Abstract INTRODUCTION Research into cognitive dispersion – a cognitive process score measuring the intra‐individual variability (IIV) across a single testing session – suggests utility in neurodegenerative populations. Given widespread deficits observed in sporadic early‐onset Alzheimer's disease (EOAD), however, it is unclear if examining cognitive ...
Dustin B. Hammers +40 more
wiley +1 more source
Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy.
Mislocalization, aberrant processing and aggregation of TAR DNA-binding protein 43 (TDP-43) is found in the neurons affected by two related diseases, amyotrophic lateral sclerosis (ALS) and frontotemporal lobe dementia (FTLD).
Angela S Laird +6 more
doaj +1 more source
Serum progranulin levels are associated with frailty in middle-aged individuals.
Background and objectiveA recent study identified progranulin as a candidate biomarker for frailty, based on gene expression databases. In the present study, we investigated associations between serum progranulin levels and frailty in a population-based ...
Andrew D Nguyen +5 more
doaj +1 more source
Glucose metabolic reprogramming as a driver of immunosuppression in the tumour microenvironment
Glucose metabolic reprogramming is a central driver of immunosuppression in the tumour microenvironment, orchestrating immune dysfunction through multiple interconnected mechanisms. Glucose competition establishes a selective bioenergetic hierarchy that constrains antitumour immunity, whereas lactate accumulation and its reciprocal crosstalk with ...
Yang Wang +3 more
wiley +1 more source
Tweaking Progranulin Expression
Frontotemporal dementia (FTD) is a neurodegenerative disease, leading to behavioral changes and language difficulties. Heterozygous loss-of-function mutations in progranulin (GRN) induce haploinsufficiency of the protein and are associated with up to one-third of all genetic FTD cases worldwide.
Terryn, Joke +2 more
openaire +1 more source
Serum progranulin levels are elevated in infertile women with obesity [PDF]
Introduction: The aim of the present study was to investigate the changes in serum progranulin and sex hormone levels in infertile women with obesity.
Bostanci, Mehmet Omar; Department of Ophthalmology, Hitit University Medical School, Çorum, Türkiye +3 more
core +2 more sources
Effects of Exercise on Progranulin Levels and Gliosis in Progranulin-Insufficient Mice1,2,3
Loss-of-function mutations in progranulin (GRN) are one of the most common genetic causes of frontotemporal dementia (FTD), a progressive, fatal neurodegenerative disorder with no available disease-modifying treatments. Through haploinsufficiency, these mutations reduce levels of progranulin, a protein that has neurotrophic and anti-inflammatory ...
Arrant, Andrew E. +2 more
openaire +1 more source
The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin [PDF]
Despite extensive clinical and experimental studies over the past decades, the pathogenesis and progression to the castration-resistant stage of prostate cancer remains largely unknown.
Gomella, Leonard G. +10 more
core +1 more source
Another piece in the progranulin puzzle: special binding between progranulin and prosaposin creates additional lysosomal access [PDF]
Loss-of-function mutations in the gene encoding the growth factor progranulin cause degeneration of the ageing brain in a dose-dependent manner. While heterozygous mutations result in adult onset frontotemporal dementia, the much rarer homozygous null ...
Van Damme, Philip, Philip Van Damme
core +1 more source

